Gizem Köroğlu, Gözde Dağliöz Görür, Sevtap Doğan, Büşra Yaprak Bayrak, Hakan Demir
Clinical nuclear medicine 2022 Mar 01A 56-year-old man underwent 68Ga-DOTATATE PET/CT with suspicion of a pancreatic neuroendocrine tumor. However, in this imaging, a mass with 68Ga-DOTATATE uptake was observed not in pancreas but in the duodenojejunal junction. Abdominal tomography confirmed that the heterogeneously enhanced mass was originated from duodenum. The patient was operated, and the histopathology result was evaluated as low-risk gastrointestinal stromal tumor. Although there was low or no specific binding to gastrointestinal stromal tumor cells for all 68Ga-labeled DOTA peptides, uptake of 68Ga-DOTATATE was observed incidentally in this case. Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Gizem Köroğlu, Gözde Dağliöz Görür, Sevtap Doğan, Büşra Yaprak Bayrak, Hakan Demir. Incidental Uptake of 68Ga-DOTATATE Gastrointestinal Stromal Tumor of Duodenum. Clinical nuclear medicine. 2022 Mar 01;47(3):e289-e290
PMID: 35025797
View Full Text